This was somewhat of a first for the US FDA to trust Chinese data. Shenzhen Chipscreen Bio sciences Ltd. was also awarded the Most Valued Partner for Roche R&D Center. Oncology drugs are one of their primary focuses, with individuals trained here in the US and returning to China to create their...
Posted to
The Medical Quack .... by Barbara Duck
on 11-15-2008
Filed under: Medically Related, Pharma/FDA News, Pharma, Biotech, FDA, Oncology, R and D, China pharma, Chipscreen, biosciences, HUYA
Many of the generic manufacturers started years back with knock off drugs to sell locally in India, but now the game is changing to where US Pharma is using some of the talent, which costs less than R and D individuals here in the states, to further develop existing work, in other words somewhat continue...
Posted to
The Medical Quack .... by Barbara Duck
on 09-05-2008
Filed under: Medically Related, Pharma/FDA News, Genomics, drugs, Pharma, Biotech, Cancer, FDA, Budgets, R and D, Alzheimers, Outsourcing
More additional affiliations for the FDA to gather information. In the news recently have been other agreements with companies such as Blue Cross and others who will be providing data to also study the effects of drugs through medical record information in their files, based on claims, etc. No...
Posted to
The Medical Quack .... by Barbara Duck
on 08-18-2008
Filed under: Medically Related, Technology, Insurance, Pharma/FDA News, health insurance, healthcare IT, Pharma, Biotech, FDA, Medco, Pharmacogonomics
A new possible term in the world of Biotech, Biogenerics? We currently have Pharmacogenomics working and now perhaps an interest with the Generic Drug business investing in Biotech as well or perhaps the availability of a generic without a long patent protection period? I am not quite sure...
Good insight and commentary here from the "inside" track...are members of Congress helping or stalling the progression of the FDA... will the Biotechs be able to develop and withstand some of the stringencies and additional methodologies to bring new products to market to save lives? Nice to...
CBS is doing a special report this week on drugs for cancer. This video has an interview with the Head of Oncology from the FDA and what their process is to approve drugs for cancer....and an interview with one of the Biotech companies who make the drugs explains that the US requires a whole new clinical...